Trial Profile
Randomised Phase II Clinical Trial PIONEER- A Pre-operative wIndOw Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole aloNE in Post-menopausal Patients With ER-positive Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2024
Price :
$35
*
At a glance
- Drugs Megestrol (Primary) ; Letrozole
- Indications Adenocarcinoma; Advanced breast cancer; Early breast cancer
- Focus Therapeutic Use
- Acronyms PIONEER
- 29 Jan 2024 Status changed from recruiting to completed.
- 01 Dec 2022 Status changed from active, no longer recruiting to completed.
- 02 Nov 2021 Status changed from recruiting to active, no longer recruiting.